Dubuque Bank & Trust CO Genmab A/S Transaction History

Dubuque Bank & Trust CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$26.83 - $38.57 $828,268 - $1.19 Million	-30,871 Closed	0 $0
Q1 2022 May 03, 2022	SELL	$30.95 - $39.68 $88,764 - $113,802	-2,868 Reduced 8.5%	30,871 $1.12 Million
Q4 2021 Jan 28, 2022	SELL	$35.87 - $47.12 $73,784 - $96,925	-2,057 Reduced 5.75%	33,739 $1.33 Million
Q3 2021 Nov 09, 2021	SELL	$41.55 - $48.72 $38,309 - $44,919	-922 Reduced 2.51%	35,796 $1.56 Million
Q2 2021 Jul 09, 2021	SELL	$32.88 - $44.57 $69,672 - $94,443	-2,119 Reduced 5.46%	36,718 $1.5 Million
Q1 2021 May 14, 2021	SELL	$30.92 - $44.4 $73,311 - $105,272	-2,371 Reduced 5.75%	38,837 $1.28 Million
Q4 2020 Feb 10, 2021	SELL	$33.66 - $40.76 $605,375 - $733,068	-17,985 Reduced 30.38%	41,208 $1.68 Million
Q3 2020 Oct 28, 2020	SELL	$33.07 - $38.68 $155,759 - $182,182	-4,710 Reduced 7.37%	59,193 $2.17 Million
Q2 2020 Jul 24, 2020	SELL	$20.05 - $33.89 $167,618 - $283,320	-8,360 Reduced 11.57%	63,903 $2.17 Million
Q1 2020 Apr 21, 2020	SELL	$17.15 - $25.22 $139,206 - $204,710	-8,117 Reduced 10.1%	72,263 $1.53 Million
Q4 2019 Jan 14, 2020	BUY	$18.88 - $24.14 $1.52 Million - $1.94 Million	80,380 New	80,380 $1.8 Million

236

52.5M

10.2K

25.5K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Dubuque Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Dubuque Bank & Trust CO with notifications on news.